0001493152-26-007587
SEC filingBriaCell Therapeutics Corp. announced on February 18, 2026, that it entered into an asset purchase agreement. The press release dated February 18, 2026, is attached as Exhibit 99.1 to the 8-K filing dated February 20, 2026.